S&W Seed Appoints Elizabeth Horton As Finance Chief
S&W Seed Company (NASDAQ:SANW) has appointed Elizabeth (Betsy) Horton as its Executive Vice President and Chief Financial Officer, effective November 15,…
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
S&W Seed’s Debt Insights
Shares of S&W Seed (NASDAQ:SANW) increased by 16.13% in the past three months. Before having a look at the importance of debt, let us look at how much debt S&W Seed has.
56 Biggest Movers From Yesterday
Gainers
Bakkt Holdings, Inc. (NYSE: BKKT) shares jumped 234.4% to close at $30.60 on Monday after the company and Mastercard announced a partnership for crypto and loyalty solutions.
S&W Seed: Q4 Earnings Insights
S&W Seed(NASDAQ:SANW) stock fell by 4.48% on Tuesday after the company reported its Q4 earnings results on Monday, September 27, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
S&W Seed Stock Falls As FY22 Revenue Outlook Lags Consensus
S&W Seed Company (NASDAQ:SANW) reported a fourth-quarter FY21 sales decline of 11.9% year-on-year, to $22.77 million, marginally beating the analyst consensus…
S&W Seed Q4 Adj. EPS $(0.14) Beats $(0.15) Estimate, Sales $22.77M Beat $22.70M Estimate
S&W Seed (NASDAQ: SANW) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $22.77 million which beat the analyst consensus estimate of $22.70 million by 0.29 percent.
Earnings Scheduled For September 27, 2021
Companies Reporting Before The Bell
• S&W Seed (NASDAQ:SANW) is expected to report quarterly loss at $0.15 per share on revenue of $22.70 million.
48 Biggest Movers From Friday
Gainers
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media.